FRANKENIUS EQUITY AB purchased 1.0% of their position (62.97K shares) of TRISALUS LIFE SCIENCES, INC. on the open market
Open‑market purchase worth $250.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/19/2024ACC: 0001415889-24-029904
10% Owner
Since Aug 2023
+62.97K
Net shares
Net buyer
$250.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
62.97K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+62.97K
Price / share
$3.97
Trade value
$250K
% of position
1.0%
12/17/2024
6.17M→6.23M
Total
Net shares
+62.97K
Net value
$250K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/17/2024 | P · Purchase | +62.97K | $3.97 | $250K | 1.0% | 6.17M | 6.23M |
| Total | +62.97K | $250K | ||||||
Derivative Transactions0
No derivative transactions reported